发明名称 |
Spiropiperidine compounds as ORL-1 receptor antagonists |
摘要 |
As ORL-1 receptor antagonist of the formula I, its uses, and methods for its preparation are described. ORL-1 antagonists are deemed to be useful; in the treatment of depression and/or the treatment of overweight, obesity, and/or weight maintenance post treatment for overweight or obesity. Certain compounds have also demonstrated through animal models that the compounds of the present invention are useful for the treatment of migraine. |
申请公布号 |
AU2010319581(B2) |
申请公布日期 |
2013.12.19 |
申请号 |
AU20100319581 |
申请日期 |
2010.11.10 |
申请人 |
ELI LILLY AND COMPANY |
发明人 |
BENITO COLLADO, ANA BELEN;DIAZ BUEZO, NURIA;JIMENEZ-AGUADO, ALMA MARIA;LAFUENTE BLANCO, CELIA;MARTINEZ-GRAU, MARIA ANGELES;PEDREGAL-TERCERO, CONCEPCION;TOLEDO ESCRIBANO, MIGUEL ANGEL |
分类号 |
C07D495/20;A61K31/444;A61P25/00 |
主分类号 |
C07D495/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|